Thanks for that, Mega. I would say that in the short-term the probable (in my mind) lack of transformative results plus the need to finance are likely to cap the share price. Hopefully, I am wrong about pending Gochager assays. Medium-term: I suspect that this story will come good - wrt both projects. I will be very encouraged if I see material backing from a recognized Ni player...as, I am sure
...more